Smithkline Beckman Corp said itsgenetically engineered hepatitis B vaccine has receivedregulatory approval for marketing in Switzerland andLuxembourg.    The vaccine, called Engerix-B, has been approved in severalother countries, including Belgium and Hong Kong.    Smithkline said it is currently considering marketingavenues in the United States.    Merck and Co &lt;MRK> also has a genetically engineeredvaccine being marketed in several foreign markets, according toindustry sources. Reuter&#3;